Event Overview

This 3-day forum is the “must attend” event for those senior decision-makers looking to drive their medical affairs teams and departments and enhance their KOL & stakeholder engagement at all levels.

Speakers List

LARGE & MEDIUM PHARMA

Vice President Development and Chief Medical Officer
Abbvie, USA

Senior Vice President, Head of Medical Affairs EMEA
Astellas Pharma, UK

Vice President, North America Medical Affairs Hospital Business
Pfizer Biopharmaceuticals Group

Global Medical Director Endocrine & IEM
Pfizer Rare Disease, Belgium

Global Head, Real World Evidence Strategy
Biogen

SMA Program Lead/ Medical Research Operations/ MERI (Medical Evidence, Research, and Innovation)
Biogen, Switzerland

Global Medical Director, Therapeutic Area Head, CNS & Pain
Abbott, Switzerland

EMEA Medical Lead Neurology & Immunology
Merck Group, Belgium

Regional Director, Medical Science Liaisons
Novartis, USA

Director, Global Medical Excellence
Allergan, USA

SMALLER PHARMA, BIOTECH & MEDTECH

Medical Affairs Oncology Director EMEA
Kyowa Kirin, UK

Head of Hearing Science and Clinical Research
MED-EL Medical Electronics, Austria

Director, Medical Scientific Liaison, EMEA
Alimera Sciences, UK

Regulatory Affairs & Drug Safety Director
Dompé Pharmaceuticals, Italy

Regulatory Affairs Manager Biotech & Hi-tech
Dompé Pharmaceuticals, Italy

Senior Director, Medical Affairs & Operations
Voyager Therapeutics, USA

EXTERNAL STAKEHOLDERS

Member, Committee for Advanced Therapies
European Medicines Agency

(TBC)

Senior Scientific Adviser – IMI Get Real
Science Policy and Research
National Institute for Health and Care Excellence (NICE), UK

Head of the Cardiology Department
University Hospital of Geneva, Switzerland

Patient Representative & Inclusion Advocate Chair: Access Matters, Midstream,
Board Member; European Forum for Good Clinical Practice (EFGCP), Healthcare Quality Improvement Partnership (HQIP), International Foundation for Integrated Care (IFIC)

CEO
The Synergist - Patient Focused Medicine, Belgium

Program Manager
The Synergist - Patient Focused Medicine, Belgium

CEO
Patient View, UK

TECHNOLOGY COMPANIES

Customer Engineer - Government & Healthcare
Google Cloud, UK

EXPERIENCED SOLUTION PROVIDER

Account Director
OPEN Health Medical Communications, UK

Managing Director
Within3

Media

CEO & Founder
PharmaPhorum, UK

Event Structure

Photo Gallery

Event Overview

MedAffairs: Strategy & Capabilities

Day 1 - 3rd March, 2020

Stream Overview

The first day will feature several keynote presentations from VP-Level thought leaders on shaping and leading the medical affairs departments, justifying medical affairs performance through innovative metrics and tracking effectiveness of the function as an essential element of today’s pharmaceutical companies. They will be discussing the strategic drivers for medical affairs, and guidance on how to make best use of this vital function.

Speakers

Vice President Development and Chief Medical Officer
Abbvie, USA

Vice President, North America Medical Affairs Hospital Business
Pfizer Biopharmaceuticals Group

Global Medical Director, Therapeutic Area Head, CNS & Pain
Abbott, Switzerland

EMEA Medical Lead Neurology & Immunology
Merck Group, Belgium

Patient Representative & Inclusion Advocate Chair: Access Matters, Midstream,
Board Member; European Forum for Good Clinical Practice (EFGCP), Healthcare Quality Improvement Partnership (HQIP), International Foundation for Integrated Care (IFIC)

CEO
The Synergist - Patient Focused Medicine, Belgium

Account Director
OPEN Health Medical Communications, UK

Managing Director
Within3

MedAffairs: Real-World Evidence

Day 2 - Stream 1 - 4th March, 2020

Stream Overview

Generating real world evidence via observational studies and the use of patient registries is one of the fastest growing areas of pharmaceutical R&D. Such post-marketing studies are becoming increasingly important as regulatory agencies demand more long-term data which demonstrates efficacy, safety and quality. The Medical Affairs unit plays a decisive role in generating this vital evidence and this stream will present solutions to the challenges companies face in generating high-quality evidence which will communicate a compelling value argument to all necessary stakeholders.

Speakers

Global Medical Director Endocrine & IEM
Pfizer Rare Disease, Belgium

Global Head, Real World Evidence Strategy
Biogen

SMA Program Lead/ Medical Research Operations/ MERI (Medical Evidence, Research, and Innovation)
Biogen, Switzerland

Regulatory Affairs & Drug Safety Director
Dompé Pharmaceuticals, Italy

Member, Committee for Advanced Therapies
European Medicines Agency

(TBC)

Senior Scientific Adviser – IMI Get Real
Science Policy and Research
National Institute for Health and Care Excellence (NICE), UK

Customer Engineer - Government & Healthcare
Google Cloud, UK

MedAffairs: Communications & Liaison

Day 2 - Stream 2 - 4th March, 2020

Stream Overview

Medical Affairs departments are increasingly looking to implement next generation medical communication practices, to offer essential evidence-based information to stakeholders on demand, through a variety of classical, yet also increasingly digital channels. This stream will focus on two key aspects of medical communication. Firstly, issues such as: protocol writing for internal late-phase studies and research initiatives; working with External Experts (KOLs) to enhance publications, abstracts & posters and receiving proposals for investigator-initiated studies. The second section of this day will focus on Medical Scientific Marketing communications, including the review process, compliance issues, ensuring the claims made by marketing colleagues are justified and appropriately communicated and also effectively localized from global-level to country-level market requirements. The day will also feature best practice case studies on structuring, managing, and monitoring the evolving Medical Science Liaison role within your organisation. This meeting is an ideal chance to benchmark with other market leaders in this field who are utilising the unique MSL function to more effectively communicate with external experts, engage them with advanced science and demonstrate product evidence. All attending will discovery how MSLs can help regain the credibility of the pharmaceutical industry as a value-adding partner to the healthcare ecosystem.

Speakers

Regional Director, Medical Science Liaisons
Novartis, USA

Director, Global Medical Excellence
Allergan, USA

Director, Medical Scientific Liaison, EMEA
Alimera Sciences, UK

Head of the Cardiology Department
University Hospital of Geneva, Switzerland

Program Manager
The Synergist - Patient Focused Medicine, Belgium

CEO
Patient View, UK

MedAffairs: Effectivness for Small Pharma & Medtech

Day 3 - (AM) - 5th March, 2020

Stream Overview

  • Building an effective, medical affairs team with limited resources, that adds-value to external stakeholders
  • Determining what capabilities, skills, resources and team structure is realistically required to maximise performance
  • Cultural change: Transformation to a patient and stakeholder-centric organization, that is science-led
  • Maximisation of real-world evidence generation on limited budgets
  • Leveraging both classical and digital medical communication strategies with a small team to maximise dialogue with KOLs and stakeholders
  • Demonstrating the value of medical affairs to internal stakeholders

Speakers

Medical Affairs Oncology Director EMEA
Kyowa Kirin, UK

Head of Hearing Science and Clinical Research
MED-EL Medical Electronics, Austria

Regulatory Affairs Manager Biotech & Hi-tech
Dompé Pharmaceuticals, Italy

Senior Director, Medical Affairs & Operations
Voyager Therapeutics, USA

MedAffairs: Persuasion & Influence Skills

Day 3 - (PM) Training Workshop - 5th March, 2020

Stream Overview

Essential tactics to engage and understand stakeholders, influence them and communicate value-adding solutions
 
This is a unique, training course specifically tailored towards life science professionals, who are motivated to engage KOLs and external stakeholders, influence colleagues, stand out from the competition, overcome objections and better articulate the true value of their solutions.
 
What's the unmet need?
We at NextLevel Life Sciences, have a unique perspective on how life science professionals can dramatically and immediately improve their influence & persuasiveness. At our pharma and medtech industry events, we constantly observe our clients’ successful interactions, but also missed opportunities. For example, many executives in life sciences companies are true subject-matter or technical experts. Often, however, they haven't received any structured training on influence, persuasion, negotiation or “sales skills”, so are not maximising their chances of ensuring the most from each customer interaction.
 
We have recognised a strong need for a structured and interactive course which will definitely help medical and clinical affairs professionals to engage stakeholders, appreciate their needs, positively influence them, demonstrate true value and forge lasting business relationships.

Who are your trainers?

Geoff Cable                               
CEO & co-Founder                         
NextLevel Life Sciences
 

Luke Rogers
CEO & co-Founder
NextLevel Life Sciences


"We believe that sales isn't a job, it's a life skill"

Geoff and Luke are experts in soft skills, negotiation, business development, management & entrepreneurship. They have a strong track record of growing their successful company organically, through sales and marketing. Both are Australians and also CEOs and co-founders of NextLevel Life Sciences, a leading event organiser and business intelligence provider for the Biopharma and Medtech industries. Over the last 12 years, Luke and Geoff have developed, promoted and delivered hundreds of industry events, focused on cutting-edge or critical themes. These have involved thousands of senior-level attendees from all the major pharma, medtech, biotech and diagnostics companies, as well as a broad range of service providers and key industry stakeholders. NextLevel Life Sciences has a strong value proposition, an effective process, but especially a customer-centric sales philosophy.

This event will enable you to:

1) Understand how medical affairs are at the forefront of new pharmaceutical industry commercial models and what needs to be done to maximise success.
2) Discover which are the most intelligent ways to map and engage with KOLs and other prescribers, payers, patient groups, pharmacies and tomorrow’s stakeholders.
3) Measure the performance of your medical affairs team and individuals.
4) Benchmark with experts to find out the best practices in late phase research, especially observational studies, patient registries and investigator-initiated studies.
5) Discover how medical scientific liaisons, in support of commercial teams, are crucial to the communication of effectiveness, safety and cost effectiveness.
6) Get real-life experiences of medical affairs capabilities development in smaller Pharma, Biotech & MedTech companies.

PHARMA & MEDICAL DEVICE: VPs, Directors & Managers of:
Customer Relations, Medical Affairs, Medical Science Liaisons, Medical Education, Health Outcomes & Liaison, Medical Communications, Marketing, KOL & Stakeholder Engagement, Late Phase & Real-World Research, Scientific Affairs, Medical Advisors and Patient-Centricity.

Event Partners

This event is accredited for CPD (Continuing Professional Development) status

RECEIVE DISCOUNTED FLIGHTS WHEN YOU REGISTER FOR THIS EVENT WITH

Previous Attendees at MedAffairs Leaders Forum - Zurich, Switzerland, 2019

Company
Job Title
Alcon
Medical Director
Alexion
Medical Affairs Manager
Alexion
MEDICAL AFFAIRS MANAGER PNH
Almirall
Neurology and other products Medical Manager
Angelini Farmaceutica, Lda
Medical Director
Ashfield Healthcare
International Business Development Executive
Bayer Business Services
Head IT BP Research & Development
Bayer Business Services
Digital Health Innovation Manager
Bayer Business Services GmbH
IT Business Partner Medical Affairs & Pharmacovigilance
BIOCAD SK
Medical Affairs Director
Boehringer Ingelheim
Head Regional Medical Affairs
Bristol-Myers Squibb
Medical Strategy, Operations and Governance Lead
Bristol-Myers Squibb
Field Medical Lead
Bristol-Myers Squibb
Oncology Medical Lead
Bristol-Myers Squibb
Disease Area Specialist
BTG International
SVP Head Clinical Development
Celgene
Director, Biostatistics
Celgene AB
Nordic Medical Director
Celgene AB
Nordic Assoc. Medical Director
Center for Research and Interdisciplinarity (CRI)
Managing Director
Complete HealthVizion
Global Head
Complete HealthVizion
Medical Affairs Director
Covance
Senior Director
Covance
Director
CSL Behring
Associate Director Medical Affairs
Daiichi Sankyo
Medical Affairs Manager Nordics
Eli Lilly
Sen. Director Operations & Capabilities International Medical Affairs
Eli Lilly
Therapeutic Area Leader Diabetes, International Medical Affairs
Eli Lilly
Sen. Medical Director UK Hub
Erytech
Head of Medical Affairs
European Medical Association (EMA)
President
Ferring Pharmaceuticals
Chief Medical Officer, Surgical Products & Exogen
Gelesis
Vice President, Medical Affairs
GSK
Strategic Capability Director
Helsinn Healthcare
Medical Affairs Manager
Hexal AG
Global Medical Manager
Hologic
Head of Scientific Affairs
ICTA PM
Business Development
Ipsen Pharma
Head of Global Medical Information
IPSEN Pharma
Global Medical Information Manager - Oncology
IQVIA
Senior Principal Head of Real World Insights, UK & Ireland
Italfarmaco
Medical Director
Janssen
Medical Advisor
Janssen
Medical Scientific Liaison
Janssen
Director of Medical & Regulatory excellence
Janssen
S. Director Medical Excellence Hub EMEA
Janssen, Pharmaceutical Companies of Johnson and Johnson
MSL Manager
Kyowa Kirin
International Medical Affairs Consultant
Kyowa Kirin Pharma
Medical Director CEEMERIT
Kyowa Kirin Pharma
Medical Affairs Manager
Kyowa Kirin Services Ltd.
Medical Director
Maquet Cardiopulmonary Gmbh
Clinical Manager
McCann Health Medical Communications Ltd
Scientific Division Lead
McKinsey and Company
Partner
MD squared
Managing Director
Merck Group
EMEA N&I Medical Affairs Director
Monocl
Sales Director
Norgine
VP, Medical Affairs
Novartis Oncology
Medical Excellence Director, Region Europe
OM Pharma
Medical Affairs Associate
OPEN Health
Account Director
OPEN Health
Principal Consultant Patient Centred Outcomes
OPEN Health Medical Communications, UK
Account Director
Otsuka Pharmaceuticals
Senior Medical Director US Medical Affairs – Neuroscience
PatientView
Founder & CEO
PatientView
Editorial director
Pfizer
Medical Director, EMEA
Pfizer, USA
Senior Director, Enterprise Benefit Risk Medical Director Worldwide Medical and Safety | Global Medical Impact Assessment
PharmaReview
Director
Pharming Group
Vice President Medical Affairs
Philips
Senior Director, Global Medical Science Liaison
Pinnacle Wellbeing 247
CEO, Head of Clinical Services, Senior Executive Coach
Prescient Healthcare Group
President
Prescient Healthcare Group
Senior Vice President
RBW Consulting
Associate Director
RBW Consulting
Account Manager
RBW Consulting
Head of Global Talent Strategy
Rhythm Pharmaceuticals
Senior Manager Medical Communications
Roche
Medical Manager
Roche
International Medical Affairs Manager Critical Care
Roche Diagnostics
Head Medical Affairs, Global Medical and Scientific Affairs CPS
Roche Diagnostics International
International Medical Manager
Sanofi Genzyme
Vice President, Global Medical Affairs Head, Respiratory
Sorin Group Italia
Director Medical Education and Scientific Liaison
Sorin Group Italia
Global Medical Education Manager
Syneos Health
Director, Consulting
Syneos Health
Syneos One Specialist
Syneos Health
Principal, Real World and Late Phase
Syneos Health, UK
Project Specialist, Real World & Late Phase and Syneos One
Teleflex
Clinical Manager
Teva Pharmaceuticals
Medical Director, Region Europe, MSL and Digital Transformation
UCB
Vice President and Head of External Engagement & Policy, Neurology Patient Value Unit
Vifor Pharma
Medical Affairs Director
ViiV Healthcare
Director of Medical Affairs
Vynamic
Executive
Vynamic
Director
Within3
Senior Vice President, Business Partnerships
Within3
Senior Director of Business Partnerships
Zealand Pharma
Senior Project Director

EVENT TESTIMONIALS

"Highly recommended for both starters in Medical Affairs and more experienced Medical Affairs colleagues to learn about new developments in Excellence and taking Leadership in Medical Affairs roles"
Head Medical Affairs, Global Medical and Scientific Affairs CPS
Roche Diagnostics
 

“The MedAffairs Leaders Forum brought together managers from pharma/biotech and representatives from patient organizations, regulators, and service providers. In a professional, yet informal setting, valuable insights and best practices shared. Anticipating future trends was highly inspirational facilitating innovative thinking. I took important learnings, ideas, and contacts from the meeting allowing me to put new approaches into practice.”
Senior Manager, Medical Communications,
Amgen
 

“Great experience of networking with international peers from Pharma, academics and partners! I've really appreciated presentations and round tables of experts in Med Affairs area.”
Medical Education and Digital Manager
Novartis

Related Videos

Presentation

Biopharmaceutical Acceleration Model for product development and commercialization

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Clinical
Availability: FREE
  • Meeting the needs of health system stakeholders demanding both clinical and real-world evidence to inform decisions regarding product use and reimbursement
  • Case study: The benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs
Speaker

Mike D’Ambrosio
Senior Project Director, Real World & Late Phase
Syneos Health, UK

Presentation

Leveraging online discussion platforms for optimal KOL & Physician engagement

Related topics: Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global KOL engagement 
  • Which solutions can enable Pharma & MedTech to better engage & generate valuable insights from KOLs & External Experts 
  • Improving KOL engagement outcomes while maintaining regulatory compliance
Speakers

Pauline De Mari
Vaccines Innovative Medical Engagement Lead
Sanofi

Andy Bowman
Managing Director
Within3

View Agenda or Register